| Welcome to Scintellix! Scintellix is a scientific and management consultancy located in Raleigh, NC. Dedicated to optimizing the human element in technology development, Scintellix supports both strategic and tactical planning to optimize execution. We do this through application of Decide-S3 Analytics-TM - a novel methodology that clarifies decisions while aligning teams. Scintellix untangles complex problems that prevent individuals, companies and institutions from achieving their goals. Who We Serve [Case Studies] Our clients include:
for rapid execution, including Board Composition Planning, Opportunity Stratification and Human Resource Planning.
critical step management.
The Benefits We Provide Include:
|
 |
| |
 |
| |
 |
| |
 |
Recent Accomplishments: Facilitation of the Strategic Planning Process for the 37 University Clinical and Translational Science Award Program of the National Center for Research Resources. Market Assessment and Launch Initiation (Including Sales Team Recruitment and Management) for an FDA-Cleared Novel Hemostatic Textile. Board Composition Planning for a US- based Public Company: Biotechnology/ Diagnostics Sector. Board Composition Planning for a US- Based Public Company: Education Services Sector Development of Algorithm-Based Technology Opportunity Stratification for a US- Based Regenerative Medicine Company Facilitation of Municipal Strategic Planning for a Western Pennsylvania Community Leadership Planning Summit for A Major Provider of Physician Practice Groups January 26, 2010, to "Beyond the Bench" Graduate Entrepreneurship Class, University of North Carolina at Chapel Hill: "The Professional Becomes An Entrepreneur." ." February 5, 2010, to Medical School, Hannover, Germany, "Optimizing Your Biomedical Research Agenda." June 13-17, 2010, Galway, Ireland TERMIS (Tissue Engineering & Regenerative Medicine International Society Meeting): Participant in Structured Debate. February 4, 2010, to Hannover, Germany REBIRTH (Regenerative Medicine): "Strategic Directions in Tissue Engineering" July 13, 2010 "From the Clinic to Business and Back," 3d Annual Business Education Course: The Business of Regenerative Medicine: From Stem Cells to the Marketplace, Case Western Reserve University, Cleveland, Ohio. Speaking Engagements: September 9, 2010 "Enterprise and Innovation," Breaking Boundaries Conference, University of Southampton, England. October 6, 2010 "Rate Limiting Steps in the Commercialization of Tissue Engineered Medical Products," Bone-Tec, Hannover, Germany Recent Books Published: Advances in Tissue Engineering: Angiogenesis (With A. Mikos), Mary Ann Liebert Publications, 2010. Advances in Tissue Engineering: Stem Cells (With A. Mikos), Mary Ann Liebert Publications, 2010. There's A Great Future In Plastics, Scintellix Publishing, 2010 See additional books at Scintellix Publishing |
Scintellix and Cryptography: The raison d'etre Scintellix is in partnership with Genetic Engineering & Biotechnology News to create quarterly Cryptogram Challenges whose themes derive from biomedical science. These draw hundreds of participants together over a period of months to solve a complex visual puzzle. In this way, each serves as a motif for what we do when we apply Decide-S3 Analytics-TM to complex business problems - each requires a process of untangling information to achieve clarity. The history of the series is available through these links: 1. MicroArray Challenge - 2008 Meet the winners, here. Purchase the limited edition poster here. 2. Cryptogram Challenge: Elisa - 2009 Meet the winners, here. Purchase the limited edition shirt here. 3. Cryptogram Challenge: Elisa Redux - 2009 Meet the winners, here. 4. RNAi Cryptogram Challenge - 2010 - Meet the winner, here. 5. RNAI-2 Cryptogram Challenge - 2010 - Meet the winners here. 6. Electroporation Cryptogram Challenge - 2010 - Meet the winners, here. Note - In all cases but one thus far, the Cryptogram Challenges have been solved by teams. Breaking News! The Cell Counting Cryptogram Challenge, the sixth in the series of Cryptogram Challenges has recently been launched. Created by Scintellix and Genetic Engineering & Biotechnology News, the Cell Counting Cryptogram Challenge is sponsored by Bio-Rad. The first 150 registrants will receive a special t-shirt that is decorated with an image derived from the cryptogram itself, a process known as Scientific Derivative Art. Whomever first cracks the code will receive $1,500 and a benchtop device from Bio-Rad. Register for the Challenge, download the necessary Powerpoint file of the cryptogram image below and view the emerging clues by clicking here. |
Scintellix Home
Recent News:
Genetic Engineering &
Biotechnology News and
Scintellix announce the
launch of the Cell Counting
Cryptogram Challenge,
sponsored by Bio-Rad.
Genetic Engineering &
Biotechnology News and
Scintellix announce the
launch of the Cell Counting
Cryptogram Challenge,
sponsored by Bio-Rad.
